We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.88B
AUM Growth
-$383M
Cap. Flow
+$18M
Cap. Flow %
0.37%
Top 10 Hldgs %
13.07%
Holding
934
New
138
Increased
293
Reduced
289
Closed
135

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$40.2M
2
LLY icon
Eli Lilly
LLY
+$37M
3
PEP icon
PepsiCo
PEP
+$29.9M
4
WFC icon
Wells Fargo
WFC
+$19M
5
BCR
CR Bard Inc.
BCR
+$18.2M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$27.6M
2
CELG
Celgene Corp
CELG
+$25.7M
3
XOM icon
ExxonMobil
XOM
+$23.1M
4
COST icon
Costco
COST
+$22.1M
5
PAYX icon
Paychex
PAYX
+$18.2M

Sector Composition

Rank Sector Weight
1 Financials 17.87%
2 Healthcare 16.79%
3 Technology 16.66%
4 Industrials 11.2%
5 Consumer Discretionary 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAN
776
DELISTED
Gordmans Stores, Inc.
GMAN
$73K ﹤0.01%
20,900
+8,800
+73% +$40.1K
PRGX
777
DELISTED
PRGX Global, Inc.
PRGX
$72K ﹤0.01%
+19,116
New +$74.6K
DSCI
778
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$72K ﹤0.01%
+15,200
New +$98.1K
SPPI
779
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$69K ﹤0.01%
+11,600
New +$80.5K
GLPW
780
DELISTED
GLOBAL POWER EQUIPMENT GROUP INC COMMON NEW
GLPW
$68K ﹤0.01%
+18,500
New +$107K
CTIC
781
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$68K ﹤0.01%
4,680
-10,210
-69% -$176K
CORT icon
782
Corcept Therapeutics
CORT
$10.2B
$61K ﹤0.01%
+16,200
New +$82.2K
SZMK
783
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$61K ﹤0.01%
10,128
-3,186
-24% -$21.6K
AMSC icon
784
American Superconductor
AMSC
$1.48B
$59K ﹤0.01%
13,523
-68,494
-84% -$322K
AVEO
785
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$55K ﹤0.01%
4,510
+1,000
+28% +$14.5K
IMI
786
DELISTED
Intermolecular, Inc.
IMI
$50K ﹤0.01%
26,500
-32,000
-55% -$67K
BXC icon
787
BlueLinx
BXC
$455M
$49K ﹤0.01%
7,067
-670
-9% -$5.96K
TEUM
788
DELISTED
Pareteum Corporation
TEUM
$44K ﹤0.01%
+4,184
New +$37.8K
PIOI
789
DELISTED
Active Power Inc
PIOI
$44K ﹤0.01%
26,900
NSPH
790
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$37K ﹤0.01%
22,288
-60,094
-73% -$155K
FTEK icon
791
Fuel Tech
FTEK
$48.2M
$36K ﹤0.01%
19,100
-7,900
-29% -$16K
LINC icon
792
Lincoln Educational Services
LINC
$1.29B
$35K ﹤0.01%
68,448
+40,100
+141% +$41.3K
INOD icon
793
Innodata
INOD
$1.83B
$34K ﹤0.01%
14,600
-747
-5% -$1.85K
RLOC
794
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$34K ﹤0.01%
15,925
-7,900
-33% -$21.1K
ONCT
795
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$29K ﹤0.01%
+27
New +$39.5K
FAC
796
DELISTED
First Acceptance Corp.
FAC
$28K ﹤0.01%
10,357
STXS icon
797
Stereotaxis
STXS
$129M
$11K ﹤0.01%
12,228
-67,528
-85% -$66.8K
AA icon
798
Alcoa
AA
$11.7B
-414,268
Closed -$11.1M
ALNY icon
799
Alnylam Pharmaceuticals
ALNY
$36.3B
-3,940
Closed -$472K
AMKR icon
800
Amkor Technology
AMKR
$16.1B
-353,845
Closed -$2.12M

Similar funds

Jacobs Levy Equity Management's Q3 2015 Portfolio in Review

As of Q3 2015, Jacobs Levy Equity Management held 934 positions worth $4.88B, down 7.3% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management's Q3 2015 filing shows 138 new, 293 increased, 289 reduced and 135 closed positions. Its largest new stake was Accenture: 404,880 shares worth $39.8M. The largest sale was Du Pont De Nemours E I, an estimated $27.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Jacobs Levy Equity Management's largest Q3 2015 buy was Accenture: 404,880 shares worth $39.8M.
  • Jacobs Levy Equity Management added most to Eli Lilly in Q3 2015, an estimated $37M increase.
  • Jacobs Levy Equity Management's biggest Q3 2015 reduction was Du Pont De Nemours E I, cutting an estimated $27.6M.
  • Jacobs Levy Equity Management fully exited HEALTH NET INC in Q3 2015, selling an estimated $16M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.88B portfolio in Q3 2015.
  • Jacobs Levy Equity Management opened 138 new positions and closed 135 in Q3 2015.
  • Jacobs Levy Equity Management's portfolio value fell 7.3% quarter-over-quarter to $4.88B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.